Inhibition of <scp>FcRn</scp> with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double‐blind, placebo‐controlled phase 3 studies and their open‐label extension

Nichola Cooper, David J. Kuter, Rose Snipes et al.|British Journal of Haematology|2024

Cited by 13